The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective analysis of 4,474 prostate biopsies to evaluate potential treatment management impact of combined clinical-genomic risk classification.
 
Paul L. Nguyen
Stock and Other Ownership Interests - Volatilyx (I)
Consulting or Advisory Role - Astellas Pharma; Augmenix; Bayer; Biogen (I); Dendreon; Ferring; GenomeDx; GigaGen (I); Infinity Pharmaceuticals (I); Medivation; Nanobiotix
Research Funding - Astellas Pharma; Janssen; Nanobiotix; Wako Diagnostics (I)
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)
Travel, Accommodations, Expenses - Ferring
 
Jingbin Zhang
Employment - GenomeDx
Travel, Accommodations, Expenses - GenomeDx
 
Kasra Yousefi
Employment - GenomeDx
Travel, Accommodations, Expenses - GenomeDx
 
Elai Davicioni
Employment - GenomeDx
Leadership - GenomeDx
Stock and Other Ownership Interests - GenomeDx
Patents, Royalties, Other Intellectual Property - CANCER DIAGNOSTICS USING BIOMARKERS 20140066323
Travel, Accommodations, Expenses - GenomeDx
 
Robert Benjamin Den
Consulting or Advisory Role - GenomeDx
Speakers' Bureau - Bayer
Research Funding - GenomeDx; Medivation/Astellas
Travel, Accommodations, Expenses - GenomeDx
 
Felix Y Feng
Leadership - PFS Genomics
Stock and Other Ownership Interests - PFS Genomics
Consulting or Advisory Role - Celgene; Dendreon; EMD Serono; Ferring; GenomeDx; Janssen Oncology; Medivation/Astellas; Sanofi
Research Funding - Celgene; Varian Medical Systems
Patents, Royalties, Other Intellectual Property - I helped develop a molecular signature to predict radiation resistance in breast cancer, and this signature was patented by the University of Michigan, my employer. It is in the process of being licensed to PFS Genomics, a company that I helped found. (Inst)
 
Daniel Eidelberg Spratt
No Relationships to Disclose